Get started
Author

Manuel Hidalgo

Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose–Response Relationships
2020 · Esther Molina-Montes, Lisa Van Hoogstraten, et al. · Cancer Epidemiology Biomarkers & Prevention · 93
PDF
Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
2020 · Esther Molina-Montes, Claudia Coscia, et al. · Gut · 89
Reduced risk of pancreatic cancer associated with asthma and nasal allergies
2015 · Paulina Gomez-Rubio, Jan-Paul Zock, et al. · Gut · 85
Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case–control approaches
2018 · Paulina Gomez‐Rubio, Janet Piñero, et al. · International Journal of Cancer · 17
PDF
Preliminary results from a randomized, open-label, phase 2 study of botensilimab (BOT) with or without balstilimab (BAL) in refractory microsatellite stable metastatic colorectal cancer with no liver metastases (MSS mCRC NLM).
2025 · Marwan Fakih, Neil Howard Segal, et al. · Journal of Clinical Oncology · 13
Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis
2025 · Alberto Langtry, Raul Rabadan, et al. · Nature Communications · 4
PDF
Low type‐2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk
2025 · Jiangchuan He, Bilal Alashkar Alhamwe, et al. · International Journal of Cancer · 4
Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study
2021 · V. Rosato, P. Gómez-Rubio, et al. · European Journal of Cancer Prevention · 2
Pancreatic cancer risk in relation to lifetime smoking patterns, tobacco type, and dose-response relationships
2019 · Esther Molina Montes, Lisa van Hoogstraten, et al. · Pancreatology · 1
Patterns of comorbidity and multimorbidity in pancreatic cancer patients
2015 · Paulina Gomez-Rubio, Aldo Scarpa, et al. · Pancreatology · 1
Asthma and nasal allergies associate with reduced pancreatic cancer risk
2015 · Paulina Gomez-Rubio, Jan-Paul Zock, et al. · Pancreatology · 1
Supplementary Figure 2 from Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer Models
2026 · M. Pia Morelli, John J. Tentler, et al.
Supplementary Figure Legends 1-5 from Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer Models
2026 · M. Pia Morelli, John J. Tentler, et al.
Supplementary Figure 5 from Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer Models
2026 · M. Pia Morelli, John J. Tentler, et al.
Supplementary Figure 4 from Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer Models
2026 · M. Pia Morelli, John J. Tentler, et al.
Supplementary Figure 3 from Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer Models
2026 · M. Pia Morelli, John J. Tentler, et al.
Data from Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer Models
2026 · M. Pia Morelli, John J. Tentler, et al.
Supplementary Figure 1 from Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer Models
2026 · M. Pia Morelli, John J. Tentler, et al.
A Comprehensive Assessment of the Causal Relationship between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Study
2026 · Jiangchuan He, Sergio Sabroso-Lasa, et al. · Cancer Epidemiology Biomarkers & Prevention
Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis
2026 · Alberto Langtry, Raul Rabadan, et al. · Nature Communications
PDF
None: A Large-Scale Proteomics Resource of Circulating Extracellular Vesicles for Biomarker Discovery in Pancreatic Cancer
2024 · Bruno Bockorny, Lakshmi Muthuswamy, et al. · eLife
The protective effect of atopic diseases against pancreatic cancer is not driven by Th2-biomarkers
2023 · Jiangchuan He, Bilal Alashkar Alhamwe, et al. · Pancreatology
Leukocyte-DNA methylome explains a large proportion of the risk variability of pancreatic cancer
2021 · E. López De Maturana, L. Alonso, et al. · Pancreatology
Additional file 2 of A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer
2021 · López de Maturana, Evangelina, Rodríguez, Juan Antonio, et al. · Figshare
Additional file 4 of A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer
2021 · López de Maturana, Evangelina, Rodríguez, Juan Antonio, et al. · Figshare
Works count: 32
Citation count: 310
H-index: 5
I10-index: 5
Year
Topic
Type